X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs BIOCON LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. BIOCON LTD WOCKHARDT LTD./
BIOCON LTD
 
P/E (TTM) x -18.4 79.3 - View Chart
P/BV x 3.0 7.5 40.5% View Chart
Dividend Yield % 1.1 0.2 656.6%  

Financials

 WOCKHARDT LTD.   BIOCON LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
BIOCON LTD
Mar-17
WOCKHARDT LTD./
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,1291,162 97.2%   
Low Rs627483 129.9%   
Sales per share (Unadj.) Rs363.1194.6 186.7%  
Earnings per share (Unadj.) Rs-20.434.4 -59.4%  
Cash flow per share (Unadj.) Rs-7.048.3 -14.5%  
Dividends per share (Unadj.) Rs10.001.00 1,000.0%  
Dividend yield (eoy) %1.10.1 936.4%  
Book value per share (Unadj.) Rs301.8241.9 124.8%  
Shares outstanding (eoy) m110.55200.00 55.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.2 57.2%   
Avg P/E ratio x-42.923.9 -179.7%  
P/CF ratio (eoy) x-125.917.0 -738.9%  
Price / Book Value ratio x2.93.4 85.6%  
Dividend payout %-48.92.9 -1,682.7%   
Avg Mkt Cap Rs m97,063164,440 59.0%   
No. of employees `0006.89.2 73.3%   
Total wages/salary Rs m9,6657,470 129.4%   
Avg. sales/employee Rs Th5,931.84,213.9 140.8%   
Avg. wages/employee Rs Th1,428.1809.0 176.5%   
Avg. net profit/employee Rs Th-334.0745.2 -44.8%   
INCOME DATA
Net Sales Rs m40,14638,911 103.2%  
Other income Rs m1,1431,571 72.7%   
Total revenues Rs m41,28940,482 102.0%   
Gross profit Rs m1289,795 1.3%  
Depreciation Rs m1,4892,772 53.7%   
Interest Rs m2,253260 866.4%   
Profit before tax Rs m-2,4728,334 -29.7%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2111,616 -13.1%   
Profit after tax Rs m-2,2606,881 -32.8%  
Gross profit margin %0.325.2 1.3%  
Effective tax rate %8.519.4 44.0%   
Net profit margin %-5.617.7 -31.8%  
BALANCE SHEET DATA
Current assets Rs m46,16040,477 114.0%   
Current liabilities Rs m19,25816,783 114.7%   
Net working cap to sales %67.060.9 110.0%  
Current ratio x2.42.4 99.4%  
Inventory Days Days10160 169.0%  
Debtors Days Days9483 113.5%  
Net fixed assets Rs m40,16545,073 89.1%   
Share capital Rs m5531,000 55.3%   
"Free" reserves Rs m32,81447,377 69.3%   
Net worth Rs m33,36748,377 69.0%   
Long term debt Rs m31,90321,082 151.3%   
Total assets Rs m89,68793,942 95.5%  
Interest coverage x-0.133.1 -0.3%   
Debt to equity ratio x1.00.4 219.4%  
Sales to assets ratio x0.40.4 108.1%   
Return on assets %07.6 -0.1%  
Return on equity %-6.814.2 -47.6%  
Return on capital %-0.312.6 -2.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12112,988 70.2%   
Fx outflow Rs m2,1337,899 27.0%   
Net fx Rs m6,9885,089 137.3%   
CASH FLOW
From Operations Rs m-2,6956,400 -42.1%  
From Investments Rs m-6,863-4,985 137.7%  
From Financial Activity Rs m12,545-1,775 -706.8%  
Net Cashflow Rs m3,010-473 -636.4%  

Share Holding

Indian Promoters % 74.5 40.4 184.4%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 2.3 8.4 27.4%  
FIIs % 7.7 10.7 72.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 19.9 77.4%  
Shareholders   67,757 109,995 61.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PFIZER  ABBOTT INDIA  PLETHICO PHARMA  WYETH LTD  GSK PHARMA  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; IT Stocks Top Gainers(01:30 pm)

After opening the day marginally higher, share markets in India continued the momentum and are presently trading in green. Sectoral indices are trading on a mixed note, with stocks in the IT sector.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - NATCO PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS